INTRODUCTION: Off-pump transapical aortic valve implantation (TA-TAVI) through mini-thoracotomy was first performed in Vancouver, Canada in October 2005. The objective of this manuscript is to describe the Vancouver experience with 178 TA-TAVI cases in symptomatic severe aortic stenosis (AS) since 2005. METHODS: Baseline characteristics and in-hospital outcomes were calculated for the overall cohort. To compare pre-procedure and post-procedure echocardiographic measurements, one way analysis of variance was utilized, followed by Tukey's HSD. In-hospital outcomes were compared between early and late cohorts using Z-test and chi-squared test as appropriate. Kaplan-Meier analysis was used to generate 3-year survival curves. The Log-rank test was used to compare survival between low-risk and high-risk groups, based on STS score. RESULTS: Between October 2005-March 2012, TA-TAVI was performed in 178 patients. Mean age was 80.5±8.6 years. Congestive heart failure and renal failure were more common in the late cohort, while previous myocardial infarction was more common in the early cohort (P<0.05). Eleven patients (6.2%) had significant intra-operative complications, including death (1.7%), conversion to CPB (3.9%), and valve embolization (1.1%). In-hospital survival was 87.9%. Mean length of hospital stay was 12.2±17.1 days. In-hospital incidence of stroke was 3.4%. Bleeding (20.2% vs. 4.7%) and vascular (14.6% vs. 3.5%) complications were more common in the early cohort. Echocardiography demonstrated a significant increase in aortic valve area and decrease in mean transvalvular gradient post-procedure. These improvements were maintained throughout the 3-year follow-up period. Overall survival was 72.1% at 6 months, 67.7% at 12 months, 55.5% at 24 months, and 47.3% at 36 months. Repeated Kaplan-Meier analysis for the 2 groups stratified by STS score, demonstrated improved survival in the low-risk group (Log-rank P=0.039). CONCLUSIONS: Among patients with symptomatic severe AS at high risk for conventional AVR, TA-TAVI is a reasonable therapeutic option with acceptable risk. Long-term survival appears to be superior in lower-risk patients.
INTRODUCTION: Off-pump transapical aortic valve implantation (TA-TAVI) through mini-thoracotomy was first performed in Vancouver, Canada in October 2005. The objective of this manuscript is to describe the Vancouver experience with 178 TA-TAVI cases in symptomatic severe aortic stenosis (AS) since 2005. METHODS: Baseline characteristics and in-hospital outcomes were calculated for the overall cohort. To compare pre-procedure and post-procedure echocardiographic measurements, one way analysis of variance was utilized, followed by Tukey's HSD. In-hospital outcomes were compared between early and late cohorts using Z-test and chi-squared test as appropriate. Kaplan-Meier analysis was used to generate 3-year survival curves. The Log-rank test was used to compare survival between low-risk and high-risk groups, based on STS score. RESULTS: Between October 2005-March 2012, TA-TAVI was performed in 178 patients. Mean age was 80.5±8.6 years. Congestive heart failure and renal failure were more common in the late cohort, while previous myocardial infarction was more common in the early cohort (P<0.05). Eleven patients (6.2%) had significant intra-operative complications, including death (1.7%), conversion to CPB (3.9%), and valve embolization (1.1%). In-hospital survival was 87.9%. Mean length of hospital stay was 12.2±17.1 days. In-hospital incidence of stroke was 3.4%. Bleeding (20.2% vs. 4.7%) and vascular (14.6% vs. 3.5%) complications were more common in the early cohort. Echocardiography demonstrated a significant increase in aortic valve area and decrease in mean transvalvular gradient post-procedure. These improvements were maintained throughout the 3-year follow-up period. Overall survival was 72.1% at 6 months, 67.7% at 12 months, 55.5% at 24 months, and 47.3% at 36 months. Repeated Kaplan-Meier analysis for the 2 groups stratified by STS score, demonstrated improved survival in the low-risk group (Log-rank P=0.039). CONCLUSIONS: Among patients with symptomatic severe AS at high risk for conventional AVR, TA-TAVI is a reasonable therapeutic option with acceptable risk. Long-term survival appears to be superior in lower-risk patients.
Authors: Martin B Leon; Nicolo Piazza; Eugenia Nikolsky; Eugene H Blackstone; Donald E Cutlip; Arie Pieter Kappetein; Mitchell W Krucoff; Michael Mack; Roxana Mehran; Craig Miller; Marie-angéle Morel; John Petersen; Jeffrey J Popma; Johanna J M Takkenberg; Alec Vahanian; Gerrit-Anne van Es; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys Journal: J Am Coll Cardiol Date: 2011-01-07 Impact factor: 24.094
Authors: Jian Ye; Anson Cheung; Samuel V Lichtenstein; Ronald G Carere; Christopher R Thompson; Sanjeewan Pasupati; John G Webb Journal: J Thorac Cardiovasc Surg Date: 2006-05 Impact factor: 5.209
Authors: Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock Journal: N Engl J Med Date: 2011-06-05 Impact factor: 91.245
Authors: Alexander B Willson; John G Webb; Troy M Labounty; Stephan Achenbach; Robert Moss; Miriam Wheeler; Christopher Thompson; James K Min; Ronen Gurvitch; Bjarne L Norgaard; Cameron J Hague; Stefan Toggweiler; Ronald Binder; Melanie Freeman; Rohan Poulter; Steen Poulsen; David A Wood; Jonathon Leipsic Journal: J Am Coll Cardiol Date: 2012-02-22 Impact factor: 24.094
Authors: Samuel V Lichtenstein; Anson Cheung; Jian Ye; Christopher R Thompson; Ronald G Carere; Sanjeevan Pasupati; John G Webb Journal: Circulation Date: 2006-07-31 Impact factor: 29.690
Authors: Jennifer Higgins; Jian Ye; Karin H Humphries; Anson Cheung; David A Wood; John G Webb; Samuel V Lichtenstein Journal: J Thorac Cardiovasc Surg Date: 2011-05-17 Impact factor: 5.209
Authors: Jian Ye; Anson Cheung; Samuel V Lichtenstein; Sanjeevan Pasupati; Ronald G Carere; Christopher R Thompson; Ajay Sinhal; John G Webb Journal: Eur J Cardiothorac Surg Date: 2006-11-28 Impact factor: 4.191
Authors: Jian Ye; Anson Cheung; Samuel V Lichtenstein; Fabian Nietlispach; Saad Albugami; Jean-Bernard Masson; Christopher R Thompson; Brad Munt; Robert Moss; Ronald G Carere; W R Eric Jamieson; John G Webb Journal: J Thorac Cardiovasc Surg Date: 2010-05 Impact factor: 5.209
Authors: Jian Ye; Anson Cheung; Samuel V Lichtenstein; Lukas A Altwegg; Daniel R Wong; Ronald G Carere; Christopher R Thompson; Robert R Moss; Brad Munt; Sanjeevan Pasupati; Robert H Boone; Jean-Bernard Masson; Abdullah Al Ali; John G Webb Journal: J Thorac Cardiovasc Surg Date: 2008-10-23 Impact factor: 5.209
Authors: Laura Besola; Anson Cheung; Jian Ye; Myriam Akodad; Andrew Chatfield; Gnalini Sathananthan; Robert Moss; John Webb Journal: Ann Cardiothorac Surg Date: 2021-09
Authors: Nestoras Papadopoulos; Ali El-Sayed Ahmad; Marlene Thudt; Stephan Fichtlscherer; Patrick Meybohm; Christian Reyher; Anton Moritz; Andreas Zierer Journal: J Cardiothorac Surg Date: 2016-04-11 Impact factor: 1.637